Basilea's US phase III HANDEL study with investigational compound oral ... Reuters In this randomized, double-blind, placebo-controlled multicenter study, 596 adult patients with severe chronic hand eczema unresponsive to potent topical corticosteroids were randomized either to a once-daily dose of 30 mg alitretinoin or placebo for a ... Basilea's Eczema Drug Alitretinoin Meets US Late-stage Study Goals Basilea Says U.S. Phase III HANDEL Study With Oral Alitretinoin Meets Endpoints |
